search
for
 About Bioline  All Journals  Testimonials  Membership  News


Neurology India
Medknow Publications on behalf of the Neurological Society of India
ISSN: 0028-3886
EISSN: 0028-3886
Vol. 51, No. 2, 2003, pp. 208-210
Bioline Code: ni03065
Full paper language: English
Document type: Research Article
Document available free of charge

Neurology India, Vol. 51, No. 2, 2003, pp. 208-210

 en Nadroparin plus aspirin versus aspirin alone in the treatment of acute ischemic stroke
G. R. K. Sarma, A. K. Roy

Abstract

Low-molecular-weight-heparin (LMWH) has been widely used in the treatment of acute ischemic stroke but controlled trials are few. In this study, 40 patients with acute ischemic stroke of less than 24 hours duration were randomized to receive either aspirin (325 mg/day) alone or aspirin (325 mg/day) plus subcutaneous nadroparin 4100 units/day. At the end of 4 weeks, the morbidity and mortality were significantly less in the nadroparin group as compared to the aspirin group. There was no increased risk of clinically significant intracranial hemorrhage in either group. The combination of aspirin and LMWH deserves to be tested in larger studies.

Keywords
Ischemic stroke, Nadroparin, Heparin

 
© Copyright 2003 Neurology India. Online full text also at http://www.neurologyindia.com
Alternative site location: http://www.neurologyindia.com

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil